Wisconsin Biohealth
Feb 3, 2026 12:00:00 AM
Axio BioPharma Named ICP Round 1 Awardee, Advancing AI-Ready Biologics Manufacturing in Wisconsin
Madison, WI (February 3, 2026) — Axio BioPharma, an AI-ready biologics contract development and manufacturing organization (CDMO), today announced it has been selected as a Round 1 awardee of the Innovation to Commercialization Pipeline (ICP) program, led by Forward BIOLABS in partnership with BioForward Wisconsin.
Read more →
